Elaine R. Wedral is Director at BALCHEM CORP (BCPC). They have made 11 open-market trades across 2 companies since 2008, most recently 2022-04-28.
CIK 0001267533
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $26K since 2008, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SXT | SELL | 2021-03-08 | 2021-03-10 | $78.55 | $157K | -3.7% | -1.9% | +10.6% |
| SXT | SELL | 2021-03-04 | 2021-03-08 | $75.75 | $303K | +1.0% | -1.2% | +12.7% |
| BCPC | SELL | 2013-12-18 | 2013-12-24 | $57.48 | $345K | -6.6% | -3.0% | -3.0% |
| BCPC | SELL | 2013-12-17 | 2013-12-19 | $57.13 | $471K | -6.6% | -3.0% | -3.0% |
| BCPC | SELL | 2013-12-13 | 2013-12-17 | $56.23 | $281K | -6.6% | -3.0% | -3.0% |
| BCPC | SELL | 2013-06-18 | 2013-06-19 | $46.00 | $206K | -6.6% | -3.0% | -3.0% |
| BCPC | SELL | 2013-06-13 | 2013-06-14 | $45.96 | $184K | -6.6% | -3.0% | -3.0% |
| BCPC | SELL | 2011-11-30 | 2011-12-02 | $40.50 | $608K | -6.6% | -3.0% | -3.0% |
| BCPC | SELL | 2011-11-28 | 2011-11-29 | $39.42 | $394K | -6.6% | -3.0% | -3.0% |
| BCPC | SELL | 2010-12-01 | 2010-12-03 | $31.61 | $346K | -6.6% | -3.0% | -3.0% |
| BCPC | BUY | 2008-12-08 | 2008-12-10 | $25.95 | $26K | -6.6% | -3.0% | -3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.